Epigenetic modifications in KDM lysine demethylases associate with survival of early-stage NSCLC
Abstract Background KDM lysine demethylase family members are related to lung cancer clinical outcomes and are potential biomarkers for chemotherapeutics. However, little is known about epigenetic alterations in KDM genes and their roles in lung cancer survival. Methods Tumor tissue samples of 1230...
| Published in: | Clinical Epigenetics |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2018-04-01
|
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s13148-018-0474-3 |
